Overview
Vlastimil Scudla practices in Olomouc, Czech Republic. Scudla is rated as a Distinguished expert by MediFind in the treatment of Multiple Myeloma. Their top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Light Chain Deposition Disease (LCDD), and Plasmacytoma.
Their clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 36 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaScudla isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Light Chain Deposition Disease (LCDD)
- PlasmacytomaScudla isAdvanced. Learn about Plasmacytoma.
- Experienced
- Cardiac AmyloidosisScudla isExperienced. Learn about Cardiac Amyloidosis.
- Primary AmyloidosisScudla isExperienced. Learn about Primary Amyloidosis.
- Smoldering Multiple MyelomaScudla isExperienced. Learn about Smoldering Multiple Myeloma.